1:"$Sreact.fragment"
2:I[27657,["/big-wins-microsite/_next/static/chunks/4a739bd2793e6bae.js","/big-wins-microsite/_next/static/chunks/052878a5ae05607c.js"],"default"]
3:I[21061,["/big-wins-microsite/_next/static/chunks/4a739bd2793e6bae.js","/big-wins-microsite/_next/static/chunks/052878a5ae05607c.js"],"default"]
8:I[22016,["/big-wins-microsite/_next/static/chunks/4a739bd2793e6bae.js","/big-wins-microsite/_next/static/chunks/052878a5ae05607c.js"],""]
e:I[58254,["/big-wins-microsite/_next/static/chunks/4a739bd2793e6bae.js","/big-wins-microsite/_next/static/chunks/052878a5ae05607c.js"],"default"]
19:I[97367,["/big-wins-microsite/_next/static/chunks/ff1a16fafef87110.js","/big-wins-microsite/_next/static/chunks/7340adf74ff47ec0.js"],"OutletBoundary"]
1a:"$Sreact.suspense"
1d:I[71613,["/big-wins-microsite/_next/static/chunks/4a739bd2793e6bae.js","/big-wins-microsite/_next/static/chunks/052878a5ae05607c.js"],"default"]
0:{"buildId":"vjLqafrZnBqqJ1duzA4cf","rsc":["$","$1","c",{"children":[[["$","$L2",null,{}],["$","section",null,{"className":"relative bg-gradient-to-br from-[#0a2540] via-[#0d3d5c] to-sil-primary text-white py-16 md:py-24 overflow-hidden","children":[["$","div",null,{"className":"absolute inset-0 opacity-10","children":[["$","div",null,{"className":"absolute top-0 right-0 w-96 h-96 bg-sil-teal-1 rounded-full blur-3xl transform translate-x-1/2 -translate-y-1/2"}],["$","div",null,{"className":"absolute bottom-0 left-0 w-96 h-96 bg-sil-primary rounded-full blur-3xl transform -translate-x-1/2 translate-y-1/2"}]]}],["$","div",null,{"className":"absolute inset-0 opacity-[0.02] mix-blend-overlay pointer-events-none","style":{"backgroundImage":"url(\"data:image/svg+xml,%3Csvg viewBox='0 0 400 400' xmlns='http://www.w3.org/2000/svg'%3E%3Cfilter id='noiseFilter'%3E%3CfeTurbulence type='fractalNoise' baseFrequency='0.9' numOctaves='4' stitchTiles='stitch'/%3E%3C/filter%3E%3Crect width='100%25' height='100%25' filter='url(%23noiseFilter)'/%3E%3C/svg%3E\")","backgroundRepeat":"repeat","backgroundSize":"180px 180px"}}],["$","div",null,{"className":"relative max-w-6xl mx-auto px-6 sm:px-8 lg:px-12","children":[["$","div",null,{"className":"flex items-center gap-6 mb-8","children":[["$","div",null,{"className":"relative","children":[["$","div",null,{"className":"absolute inset-0 bg-sil-teal-1/20 rounded-xl blur-xl"}],["$","div",null,{"className":"relative flex items-center justify-center w-16 h-16 md:w-20 md:h-20 bg-white/20 backdrop-blur-md rounded-xl border border-white/30 shadow-2xl","children":["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","viewBox":"0 0 24 24","fill":"currentColor","aria-hidden":"true","data-slot":"icon","className":"w-8 h-8 md:w-10 md:h-10 text-white drop-shadow-lg","children":[null,["$","path",null,{"fillRule":"evenodd","d":"M10.5 3.798v5.02a3 3 0 0 1-.879 2.121l-2.377 2.377a9.845 9.845 0 0 1 5.091 1.013 8.315 8.315 0 0 0 5.713.636l.285-.071-3.954-3.955a3 3 0 0 1-.879-2.121v-5.02a23.614 23.614 0 0 0-3 0Zm4.5.138a.75.75 0 0 0 .093-1.495A24.837 24.837 0 0 0 12 2.25a25.048 25.048 0 0 0-3.093.191A.75.75 0 0 0 9 3.936v4.882a1.5 1.5 0 0 1-.44 1.06l-6.293 6.294c-1.62 1.621-.903 4.475 1.471 4.88 2.686.46 5.447.698 8.262.698 2.816 0 5.576-.239 8.262-.697 2.373-.406 3.092-3.26 1.47-4.881L15.44 9.879A1.5 1.5 0 0 1 15 8.818V3.936Z","clipRule":"evenodd"}]]}]}]]}],["$","div",null,{"className":"inline-block bg-white/15 backdrop-blur-sm px-4 py-2 rounded-full border border-white/25","children":["$","span",null,{"className":"text-white/90 font-medium text-xs md:text-sm tracking-wide","children":"Public Health / Harm Reduction"}]}]]}],["$","h1",null,{"className":"text-4xl md:text-5xl lg:text-6xl font-bold mb-8 leading-tight max-w-4xl","children":"Syringe Services Programs (Needle Exchange)"}],["$","div",null,{"className":"mb-10","children":["$","$L3",null,{"value":"97% HIV prevention effectiveness","className":"text-5xl md:text-6xl lg:text-7xl font-bold text-white block mb-2 drop-shadow-[0_0_30px_rgba(74,227,201,0.25)]"}]}],["$","div",null,{"className":"grid grid-cols-1 md:grid-cols-2 gap-6 text-white/90","children":[["$","div",null,{"children":[["$","p",null,{"className":"text-xs font-semibold text-white/70 uppercase tracking-wider mb-2","children":"Timespan"}],["$","p",null,{"className":"text-base","children":"1985-present"}]]}],["$","div",null,{"children":[["$","p",null,{"className":"text-xs font-semibold text-white/70 uppercase tracking-wider mb-2","children":"Key Researchers"}],["$","p",null,{"className":"text-base","children":"Don Des Jarlais, Robert Heimer, David Vlahov"}]]}]]}]]}]]}],["$","div",null,{"className":"max-w-7xl mx-auto px-4 sm:px-6 lg:px-8 py-12","children":["$","div",null,{"className":"flex gap-12","children":[["$","nav",null,{"className":"hidden lg:block w-64 flex-shrink-0","aria-label":"Case studies navigation","children":"$L4"}],"$L5"]}]}]],["$L6"],"$L7"]}],"loading":null,"isPartial":false}
4:["$","div",null,{"className":"sticky top-24","children":[["$","h2",null,{"className":"text-sm font-bold text-gray-500 uppercase tracking-wider mb-4","children":"All Case Studies"}],["$","ul",null,{"className":"space-y-2","children":[["$","li","amc-vaccines",{"children":["$","$L8",null,{"href":"/case-studies/amc-vaccines","className":"flex items-center gap-3 px-3 py-2 rounded-lg transition-colors text-gray-700 hover:bg-gray-100 hover:text-sil-red-2","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","viewBox":"0 0 24 24","fill":"currentColor","aria-hidden":"true","data-slot":"icon","className":"w-5 h-5 flex-shrink-0 text-sil-red-1","children":[null,["$","path",null,{"d":"M12 7.5a2.25 2.25 0 1 0 0 4.5 2.25 2.25 0 0 0 0-4.5Z"}],["$","path",null,{"fillRule":"evenodd","d":"M1.5 4.875C1.5 3.839 2.34 3 3.375 3h17.25c1.035 0 1.875.84 1.875 1.875v9.75c0 1.036-.84 1.875-1.875 1.875H3.375A1.875 1.875 0 0 1 1.5 14.625v-9.75ZM8.25 9.75a3.75 3.75 0 1 1 7.5 0 3.75 3.75 0 0 1-7.5 0ZM18.75 9a.75.75 0 0 0-.75.75v.008c0 .414.336.75.75.75h.008a.75.75 0 0 0 .75-.75V9.75a.75.75 0 0 0-.75-.75h-.008ZM4.5 9.75A.75.75 0 0 1 5.25 9h.008a.75.75 0 0 1 .75.75v.008a.75.75 0 0 1-.75.75H5.25a.75.75 0 0 1-.75-.75V9.75Z","clipRule":"evenodd"}],["$","path",null,{"d":"M2.25 18a.75.75 0 0 0 0 1.5c5.4 0 10.63.722 15.6 2.075 1.19.324 2.4-.558 2.4-1.82V18.75a.75.75 0 0 0-.75-.75H2.25Z"}]]}],["$","span",null,{"className":"text-sm leading-tight","children":"Advance Market Commitment for Pneumococcal Vaccines"}]]}]}],["$","li","behavioral-nudges",{"children":["$","$L8",null,{"href":"/case-studies/behavioral-nudges","className":"flex items-center gap-3 px-3 py-2 rounded-lg transition-colors text-gray-700 hover:bg-gray-100 hover:text-sil-red-2","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","viewBox":"0 0 24 24","fill":"currentColor","aria-hidden":"true","data-slot":"icon","className":"w-5 h-5 flex-shrink-0 text-sil-red-1","children":[null,["$","path",null,{"d":"M12 .75a8.25 8.25 0 0 0-4.135 15.39c.686.398 1.115 1.008 1.134 1.623a.75.75 0 0 0 .577.706c.352.083.71.148 1.074.195.323.041.6-.218.6-.544v-4.661a6.714 6.714 0 0 1-.937-.171.75.75 0 1 1 .374-1.453 5.261 5.261 0 0 0 2.626 0 .75.75 0 1 1 .374 1.452 6.712 6.712 0 0 1-.937.172v4.66c0 .327.277.586.6.545.364-.047.722-.112 1.074-.195a.75.75 0 0 0 .577-.706c.02-.615.448-1.225 1.134-1.623A8.25 8.25 0 0 0 12 .75Z"}],["$","path",null,{"fillRule":"evenodd","d":"M9.013 19.9a.75.75 0 0 1 .877-.597 11.319 11.319 0 0 0 4.22 0 .75.75 0 1 1 .28 1.473 12.819 12.819 0 0 1-4.78 0 .75.75 0 0 1-.597-.876ZM9.754 22.344a.75.75 0 0 1 .824-.668 13.682 13.682 0 0 0 2.844 0 .75.75 0 1 1 .156 1.492 15.156 15.156 0 0 1-3.156 0 .75.75 0 0 1-.668-.824Z","clipRule":"evenodd"}]]}],["$","span",null,{"className":"text-sm leading-tight","children":"Behavioral Nudges"}]]}]}],["$","li","dice-modeling",{"children":["$","$L8",null,{"href":"/case-studies/dice-modeling","className":"flex items-center gap-3 px-3 py-2 rounded-lg transition-colors text-gray-700 hover:bg-gray-100 hover:text-sil-red-2","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","viewBox":"0 0 24 24","fill":"currentColor","aria-hidden":"true","data-slot":"icon","className":"w-5 h-5 flex-shrink-0 text-sil-red-1","children":[null,["$","path",null,{"d":"m11.645 20.91-.007-.003-.022-.012a15.247 15.247 0 0 1-.383-.218 25.18 25.18 0 0 1-4.244-3.17C4.688 15.36 2.25 12.174 2.25 8.25 2.25 5.322 4.714 3 7.688 3A5.5 5.5 0 0 1 12 5.052 5.5 5.5 0 0 1 16.313 3c2.973 0 5.437 2.322 5.437 5.25 0 3.925-2.438 7.111-4.739 9.256a25.175 25.175 0 0 1-4.244 3.17 15.247 15.247 0 0 1-.383.219l-.022.012-.007.004-.003.001a.752.752 0 0 1-.704 0l-.003-.001Z"}]]}],["$","span",null,{"className":"text-sm leading-tight","children":"DICE Model: Climate-Economy Policy Modeling"}]]}]}],"$L9","$La","$Lb","$Lc","$Ld"]}]]}]
f:T65d,<p>Syringe Services Programs (SSPs), also known as needle exchange programs, represent a foundational harm reduction strategy that dramatically reduced blood-borne infections among people who inject drugs. At the height of the AIDS epidemic in the 1980s-1990s, injection drug use accounted for nearly 40% of AIDS cases in the U.S. and over 70% of HIV infections among women of childbearing age. SSPs—which provide sterile needles and ancillary services like counseling and medical referrals—emerged from underground activist movements in the mid-1980s, faced intense political and legal opposition, and gradually achieved mainstream acceptance through accumulating research evidence.</p>
<p>The impact has been substantial. SSPs are associated with 40-60% reductions in HIV transmission and 76% reductions in hepatitis C transmission in regions with high program coverage. In New York City, as annual syringe exchanges increased from 250,000 to 3 million, HIV prevalence among people who inject drugs declined from 50% to 15%. Today, approximately 500 SSPs operate across the United States, serving as entry points not only for sterile equipment but also for addiction treatment, HIV care, and overdose prevention services. The rise of SSPs illustrates how community-driven innovation, rigorous evaluation research, and strategic policy advocacy can overcome intense political opposition to save lives at scale.</p>
<blockquote>
<p>"Nearly 30 years of research shows that use of SSPs in the United States is associated with a 40-60% reduction in HIV transmission." — National Institute on Drug Abuse, 2024</p>
</blockquote>10:T475,<ul>
<li><strong>40-60% reduction</strong> in HIV transmission where SSPs operate (<a href="https://nida.nih.gov/about-nida/noras-blog/2024/11/syringe-services-for-people-who-inject-drugs-are-enormously-effective-but-remain-underused">NIDA, 2024</a>)</li>
<li><strong>76% reduction</strong> in hepatitis C transmission in Europe with high SSP coverage (<a href="https://nida.nih.gov/about-nida/noras-blog/2024/11/syringe-services-for-people-who-inject-drugs-are-enormously-effective-but-remain-underused">NIDA, 2024</a>)</li>
<li><strong>50% to 15% HIV prevalence decline</strong> in NYC as exchanges increased from 250K to 3M syringes annually (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4785082/">Des Jarlais et al., PMC</a>)</li>
<li><strong>7.6x return on investment</strong>: $10M additional investment averts $76M in treatment costs (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4211599/">2014 study, PMC</a>)</li>
<li><strong>~500 SSPs nationwide</strong> (2024), unevenly distributed—California has 58, Kentucky 45, but five states have none (<a href="https://www.ncbi.nlm.nih.gov/books/NBK598964/">NCBI</a>)</li>
</ul>11:T7b8,<p><strong>Key Researchers and Institutions:</strong></p>
<ul>
<li>Don Des Jarlais (NYU) - pioneering NYC studies on risk reduction</li>
<li>Robert Heimer (Yale) - New Haven mathematical modeling study</li>
<li>David Vlahov, Steffanie Strathdee, Holly Hagan - cross-site comparative research</li>
<li>Jon Parker (Yale student) - founded underground AIDS Brigade in New Haven, 1986</li>
</ul>
<p><strong>Major Publications &#x26; Reports:</strong></p>
<ul>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/4051350/">Des Jarlais, 1985</a>: Early NYC study documenting risk reduction potential</li>
<li><a href="https://journals.lww.com/jaids/abstract/1992/11000/a_model_based_estimate_of_hiv_infectivity_via.9.aspx">Heimer et al., 1992-1993</a>: First federally funded SSP evaluation—New Haven study using mathematical modeling estimated 33% reduction in HIV incidence</li>
<li><a href="https://ajph.aphapublications.org/doi/abs/10.2105/AJPH.85.11.1531">Hagan et al., 1995</a>: Tacoma study provided direct evidence using hepatitis B/C as HIV surrogates</li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/8855855/">Des Jarlais et al., 1996</a>: Large NYC study found non-SSP users 3x more likely to contract HIV than SSP users</li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/9269214/">Hurley et al., 1997</a>: Global review comparing cities with/without exchanges—cities with SSPs saw HIV decrease 5.8%/year, while cities without saw increases of 5.9%/year</li>
<li><a href="https://www.ncbi.nlm.nih.gov/books/NBK232343/">IOM Report, 1995</a>: National Academy of Medicine consensus that SSPs reduce HIV transmission without increasing drug use</li>
<li><a href="https://www.gao.gov/assets/hrd-93-60.pdf">GAO Report, 1993</a>: First U.S. government evaluation concluded SSPs "hold promise" for limiting HIV</li>
</ul>
<p>Evidence accumulated from underground activist programs → pilot evaluations → consensus reviews → federal policy change, spanning nearly 30 years.</p>12:T11c0,<p><strong>Grassroots Beginnings (1986-1988):</strong> SSPs began as illegal underground operations by activists responding to the AIDS crisis. In 1986, Yale public health student Jon Parker founded the "AIDS Brigade," operating a syringe exchange from a van in New Haven without legal authorization. Similar unsanctioned programs emerged in San Francisco, Los Angeles, Tacoma, and New York City, led by AIDS activists and people who used drugs. These programs operated in defiance of state laws prohibiting syringe possession without prescription and faced arrest risks. However, they created crucial early data points and mobilized sympathetic public health officials and researchers. The first official SSP opened in Tacoma, Washington in 1988.</p>
<p><strong>Proof of Concept (1990-1993):</strong> A breakthrough came when Connecticut authorized a one-year experimental SSP in New Haven in 1990, explicitly to gather research evidence. Supported by a $25,000 grant, Yale researchers used innovative methods—testing returned needles for HIV and mathematical modeling—to estimate program impact. They found a one-third reduction in projected HIV infections among clients. This rigorous evaluation validated the concept and provided implementation guidance (one-for-one exchanges, counseling, treatment referrals).</p>
<p>The New Haven findings triggered cascading policy changes: New York City's mayor reversed his opposition and authorized exchanges in 1991; Connecticut legalized syringe possession statewide. Simultaneously, the <a href="https://www.gao.gov/assets/hrd-93-60.pdf">1993 GAO report</a> and University of California evaluation (commissioned by the federal government) concluded SSPs showed promise for HIV prevention.</p>
<p><strong>Critical Inflection Points:</strong></p>
<p><em>Overcoming Federal Funding Ban:</em> In 1988, Congress banned using federal funds for SSPs or even research on them, severely limiting evaluation capacity and scale. This restriction remained despite accumulating evidence through the 1990s. However, the AIDS crisis among people who inject drugs continued escalating (40% of AIDS cases by 1998), creating pressure for action. Private foundations, particularly the Robert Wood Johnson Foundation, funded research when federal dollars were unavailable. The National Institute on Drug Abuse (NIDA) eventually supported SSP research through creative funding mechanisms, leading to a dramatic increase in publications—from 32 articles before 1995 to nearly double by 1996.</p>
<p>By 1998, scientific consensus was overwhelming. The Secretary of Health and Human Services declared SSPs "safe and effective," yet Congress maintained the funding ban due to political opposition framing needle exchange as condoning drug use. Instead, the federal government allowed communities to use local funds, and by the late 1990s, SSPs had spread to 28 states despite the ban.</p>
<p><em>2015 Indiana HIV Outbreak - Policy Window:</em> The pivotal moment came during the opioid epidemic. In 2015, rural Scott County, Indiana experienced a sudden outbreak of 235 HIV infections driven by prescription opioid injection. This crisis in a conservative area with no SSP forced even skeptical officials to act. Indiana Governor Mike Pence, a vocal SSP opponent, authorized a temporary emergency program that successfully contained the outbreak.</p>
<p>This real-world demonstration in a politically unlikely setting moved Congress. In 2016, appropriations language partially lifted the federal funding ban: federal health funds could now support SSP operations (staff, outreach, treatment linkages) but still not purchase needles directly. This compromise unblocked federal support while maintaining symbolic distance from "buying needles."</p>
<p><strong>Scaling Mechanisms:</strong></p>
<p>By 2020, SSPs were incorporated into the federal "Ending the HIV Epidemic" initiative. Approximately 500 programs now operate nationwide, though distribution remains uneven (California has 58, while five states have none). SSPs increasingly serve as platforms for comprehensive services: addiction treatment referral, HIV/hepatitis C testing and treatment, overdose prevention (naloxone distribution), and primary care linkage.</p>
<p>The diffusion pattern followed classic harm reduction advocacy: underground innovation → pilot demonstrations → rigorous evaluation → consensus reviews → gradual policy acceptance → institutionalization as crisis (opioid epidemic) created policy window for federal support.</p>13:T521,<p>SSPs are now mainstream public health interventions supported by CDC, NIDA, and medical associations, though political challenges persist. Recent years have seen renewed attacks on SSPs in some states, with programs closed or defunded despite evidence. The ongoing opioid and fentanyl crises have created both opportunities (recognition of need) and threats (backlash framing SSPs as enabling addiction).</p>
<p>Current research focuses on optimizing SSP models: mobile vs. fixed sites, peer-run programs, integration with medication for opioid use disorder (buprenorphine, methadone), and addressing stimulant use. There's growing recognition that SSPs alone are insufficient—they must be part of comprehensive approaches including treatment access, housing, economic opportunity, and addressing criminalization of drug use.</p>
<p>The field faces tension between evidence and politics. Research consistently shows SSPs save lives cost-effectively without increasing drug use, yet expansion remains politically fraught. Some areas experiencing outbreaks still refuse to authorize programs. The lesson: even strong evidence may be necessary but insufficient for policy change when moral opposition persists. Sustained advocacy, community partnerships, and capitalizing on policy windows remain essential.</p>14:Tbb1,<p><strong>Field Accumulation:</strong> SSP acceptance resulted from three decades of accumulating evidence—underground programs (1980s), pilot evaluations (early 1990s), comparative studies (mid-1990s), consensus reviews (IOM, GAO), long-term tracking (2000s), and crisis response demonstrations (2015). No single study transformed policy; it was the weight of converging evidence from multiple cities, methods, and research teams that eventually overcame opposition.</p>
<p><strong>Partnership vs. Public Engagement:</strong> SSPs succeeded through extensive public engagement but not traditional "partnership-based research." Early programs were activist-led, operating outside official channels. Researchers like Heimer engaged with community organizations and participants but didn't conduct formal partnership research. The model was responsive to community-identified needs (activists started programs, researchers evaluated them) rather than co-designed academic-community partnerships. This demonstrates that strong stakeholder engagement, not formal partnerships, can drive evidence-based policy change.</p>
<p><strong>Policy Windows:</strong> The 2015 Indiana HIV outbreak created a critical policy window—a crisis in an unexpected location (rural, conservative) that forced action and demonstrated SSP effectiveness to skeptical audiences. This real-world emergency provided the political cover for federal policy change after decades of evidence accumulation had failed to move Congress. The lesson: evidence creates readiness, but crises often provide the opportunity for policy breakthrough.</p>
<p><strong>Cost-Effectiveness as Political Tool:</strong> The 7.6x return on investment framing proved politically powerful, allowing SSP advocates to argue in economic terms palatable across ideologies. Preventing expensive HIV treatment saves taxpayer money—this pragmatic frame complemented moral arguments about saving lives and expanded the coalition supporting SSPs beyond traditional public health advocates.</p>
<p><strong>Implementation Flexibility:</strong> Successful SSPs adapted to local contexts—some operated from fixed storefronts, others used mobile vans; some were health department-run, others peer-led. This flexibility enabled spread across diverse political and geographic settings. The core intervention (sterile needles + ancillary services) remained constant while implementation varied, demonstrating that rigid programmatic requirements aren't necessary for evidence-based scaling.</p>
<hr>
<p><em>Sources: <a href="https://nida.nih.gov/about-nida/noras-blog/2024/11/syringe-services-for-people-who-inject-drugs-are-enormously-effective-but-remain-underused">NIDA 2024</a>, <a href="https://www.ncbi.nlm.nih.gov/books/NBK232343/">IOM 1995 Report</a>, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4785082/">Des Jarlais et al. NYC study</a>, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4211599/">2014 cost-effectiveness study</a></em></p>5:["$","article",null,{"className":"flex-1 max-w-4xl","children":[["$","nav",null,{"aria-label":"Breadcrumb","className":"mb-8","children":["$","ol",null,{"className":"flex items-center flex-wrap gap-2 text-sm","children":[["$","li","0",{"className":"flex items-center gap-2","children":[["$","$L8",null,{"href":"/","className":"text-gray-600 hover:text-sil-primary transition-colors hover:underline","children":"Home"}],["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","viewBox":"0 0 24 24","fill":"currentColor","aria-hidden":"true","data-slot":"icon","className":"w-4 h-4 text-gray-400","children":[null,["$","path",null,{"fillRule":"evenodd","d":"M16.28 11.47a.75.75 0 0 1 0 1.06l-7.5 7.5a.75.75 0 0 1-1.06-1.06L14.69 12 7.72 5.03a.75.75 0 0 1 1.06-1.06l7.5 7.5Z","clipRule":"evenodd"}]]}]]}],["$","li","1",{"className":"flex items-center gap-2","children":[["$","$L8",null,{"href":"/case-studies","className":"text-gray-600 hover:text-sil-primary transition-colors hover:underline","children":"Case Studies"}],["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","viewBox":"0 0 24 24","fill":"currentColor","aria-hidden":"true","data-slot":"icon","className":"w-4 h-4 text-gray-400","children":[null,["$","path",null,{"fillRule":"evenodd","d":"M16.28 11.47a.75.75 0 0 1 0 1.06l-7.5 7.5a.75.75 0 0 1-1.06-1.06L14.69 12 7.72 5.03a.75.75 0 0 1 1.06-1.06l7.5 7.5Z","clipRule":"evenodd"}]]}]]}],["$","li","2",{"className":"flex items-center gap-2","children":[["$","span",null,{"className":"text-gray-900 font-semibold","aria-current":"page","children":"Syringe Services Programs (Needle Exchange)"}],false]}]]}]}],["$","$Le",null,{"sections":[{"id":"overview","title":"Overview","content":"$f"},{"id":"impact-metrics","title":"Impact Metrics","content":"$10"},{"id":"scientific-foundations","title":"Scientific Foundations","content":"$11"},{"id":"path-from-science-to-impact","title":"Path from Science to Impact","content":"$12"},{"id":"current-status","title":"Current Status","content":"$13"},{"id":"lessons-exemplified","title":"Lessons Exemplified","content":"$14"}]}],"$L15",false,"$L16","$L17","$L18"]}]
6:["$","script","script-0",{"src":"/big-wins-microsite/_next/static/chunks/052878a5ae05607c.js","async":true}]
7:["$","$L19",null,{"children":["$","$1a",null,{"name":"Next.MetadataOutlet","children":"$@1b"}]}]
1c:T43f,M21.721 12.752a9.711 9.711 0 0 0-.945-5.003 12.754 12.754 0 0 1-4.339 2.708 18.991 18.991 0 0 1-.214 4.772 17.165 17.165 0 0 0 5.498-2.477ZM14.634 15.55a17.324 17.324 0 0 0 .332-4.647c-.952.227-1.945.347-2.966.347-1.021 0-2.014-.12-2.966-.347a17.515 17.515 0 0 0 .332 4.647 17.385 17.385 0 0 0 5.268 0ZM9.772 17.119a18.963 18.963 0 0 0 4.456 0A17.182 17.182 0 0 1 12 21.724a17.18 17.18 0 0 1-2.228-4.605ZM7.777 15.23a18.87 18.87 0 0 1-.214-4.774 12.753 12.753 0 0 1-4.34-2.708 9.711 9.711 0 0 0-.944 5.004 17.165 17.165 0 0 0 5.498 2.477ZM21.356 14.752a9.765 9.765 0 0 1-7.478 6.817 18.64 18.64 0 0 0 1.988-4.718 18.627 18.627 0 0 0 5.49-2.098ZM2.644 14.752c1.682.971 3.53 1.688 5.49 2.099a18.64 18.64 0 0 0 1.988 4.718 9.765 9.765 0 0 1-7.478-6.816ZM13.878 2.43a9.755 9.755 0 0 1 6.116 3.986 11.267 11.267 0 0 1-3.746 2.504 18.63 18.63 0 0 0-2.37-6.49ZM12 2.276a17.152 17.152 0 0 1 2.805 7.121c-.897.23-1.837.353-2.805.353-.968 0-1.908-.122-2.805-.353A17.151 17.151 0 0 1 12 2.276ZM10.122 2.43a18.629 18.629 0 0 0-2.37 6.49 11.266 11.266 0 0 1-3.746-2.504 9.754 9.754 0 0 1 6.116-3.985Z9:["$","li","emissions-trading",{"children":["$","$L8",null,{"href":"/case-studies/emissions-trading","className":"flex items-center gap-3 px-3 py-2 rounded-lg transition-colors text-gray-700 hover:bg-gray-100 hover:text-sil-red-2","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","viewBox":"0 0 24 24","fill":"currentColor","aria-hidden":"true","data-slot":"icon","className":"w-5 h-5 flex-shrink-0 text-sil-red-1","children":[null,["$","path",null,{"d":"$1c"}]]}],["$","span",null,{"className":"text-sm leading-tight","children":"Emissions Trading Schemes"}]]}]}]
a:["$","li","fcc-spectrum",{"children":["$","$L8",null,{"href":"/case-studies/fcc-spectrum","className":"flex items-center gap-3 px-3 py-2 rounded-lg transition-colors text-gray-700 hover:bg-gray-100 hover:text-sil-red-2","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","viewBox":"0 0 24 24","fill":"currentColor","aria-hidden":"true","data-slot":"icon","className":"w-5 h-5 flex-shrink-0 text-sil-red-1","children":[null,["$","path",null,{"d":"M18.375 2.25c-1.035 0-1.875.84-1.875 1.875v15.75c0 1.035.84 1.875 1.875 1.875h.75c1.035 0 1.875-.84 1.875-1.875V4.125c0-1.036-.84-1.875-1.875-1.875h-.75ZM9.75 8.625c0-1.036.84-1.875 1.875-1.875h.75c1.036 0 1.875.84 1.875 1.875v11.25c0 1.035-.84 1.875-1.875 1.875h-.75a1.875 1.875 0 0 1-1.875-1.875V8.625ZM3 13.125c0-1.036.84-1.875 1.875-1.875h.75c1.036 0 1.875.84 1.875 1.875v6.75c0 1.035-.84 1.875-1.875 1.875h-.75A1.875 1.875 0 0 1 3 19.875v-6.75Z"}]]}],["$","span",null,{"className":"text-sm leading-tight","children":"FCC Spectrum Licensing Reforms"}]]}]}]
b:["$","li","growth-mindset",{"children":["$","$L8",null,{"href":"/case-studies/growth-mindset","className":"flex items-center gap-3 px-3 py-2 rounded-lg transition-colors text-gray-700 hover:bg-gray-100 hover:text-sil-red-2","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","viewBox":"0 0 24 24","fill":"currentColor","aria-hidden":"true","data-slot":"icon","className":"w-5 h-5 flex-shrink-0 text-sil-red-1","children":[null,["$","path",null,{"d":"M11.7 2.805a.75.75 0 0 1 .6 0A60.65 60.65 0 0 1 22.83 8.72a.75.75 0 0 1-.231 1.337 49.948 49.948 0 0 0-9.902 3.912l-.003.002c-.114.06-.227.119-.34.18a.75.75 0 0 1-.707 0A50.88 50.88 0 0 0 7.5 12.173v-.224c0-.131.067-.248.172-.311a54.615 54.615 0 0 1 4.653-2.52.75.75 0 0 0-.65-1.352 56.123 56.123 0 0 0-4.78 2.589 1.858 1.858 0 0 0-.859 1.228 49.803 49.803 0 0 0-4.634-1.527.75.75 0 0 1-.231-1.337A60.653 60.653 0 0 1 11.7 2.805Z"}],["$","path",null,{"d":"M13.06 15.473a48.45 48.45 0 0 1 7.666-3.282c.134 1.414.22 2.843.255 4.284a.75.75 0 0 1-.46.711 47.87 47.87 0 0 0-8.105 4.342.75.75 0 0 1-.832 0 47.87 47.87 0 0 0-8.104-4.342.75.75 0 0 1-.461-.71c.035-1.442.121-2.87.255-4.286.921.304 1.83.634 2.726.99v1.27a1.5 1.5 0 0 0-.14 2.508c-.09.38-.222.753-.397 1.11.452.213.901.434 1.346.66a6.727 6.727 0 0 0 .551-1.607 1.5 1.5 0 0 0 .14-2.67v-.645a48.549 48.549 0 0 1 3.44 1.667 2.25 2.25 0 0 0 2.12 0Z"}],["$","path",null,{"d":"M4.462 19.462c.42-.419.753-.89 1-1.395.453.214.902.435 1.347.662a6.742 6.742 0 0 1-1.286 1.794.75.75 0 0 1-1.06-1.06Z"}]]}],["$","span",null,{"className":"text-sm leading-tight","children":"Growth Mindset in Education"}]]}]}]
c:["$","li","moving-to-opportunity",{"children":["$","$L8",null,{"href":"/case-studies/moving-to-opportunity","className":"flex items-center gap-3 px-3 py-2 rounded-lg transition-colors text-gray-700 hover:bg-gray-100 hover:text-sil-red-2","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","viewBox":"0 0 24 24","fill":"currentColor","aria-hidden":"true","data-slot":"icon","className":"w-5 h-5 flex-shrink-0 text-sil-red-1","children":[null,["$","path",null,{"d":"M11.47 3.841a.75.75 0 0 1 1.06 0l8.69 8.69a.75.75 0 1 0 1.06-1.061l-8.689-8.69a2.25 2.25 0 0 0-3.182 0l-8.69 8.69a.75.75 0 1 0 1.061 1.06l8.69-8.689Z"}],["$","path",null,{"d":"m12 5.432 8.159 8.159c.03.03.06.058.091.086v6.198c0 1.035-.84 1.875-1.875 1.875H15a.75.75 0 0 1-.75-.75v-4.5a.75.75 0 0 0-.75-.75h-3a.75.75 0 0 0-.75.75V21a.75.75 0 0 1-.75.75H5.625a1.875 1.875 0 0 1-1.875-1.875v-6.198a2.29 2.29 0 0 0 .091-.086L12 5.432Z"}]]}],["$","span",null,{"className":"text-sm leading-tight","children":"Moving to Opportunity"}]]}]}]
d:["$","li","needle-exchange",{"children":["$","$L8",null,{"href":"/case-studies/needle-exchange","className":"flex items-center gap-3 px-3 py-2 rounded-lg transition-colors bg-sil-red-1 text-white font-semibold","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","viewBox":"0 0 24 24","fill":"currentColor","aria-hidden":"true","data-slot":"icon","className":"w-5 h-5 flex-shrink-0 text-white","children":[null,["$","path",null,{"fillRule":"evenodd","d":"M10.5 3.798v5.02a3 3 0 0 1-.879 2.121l-2.377 2.377a9.845 9.845 0 0 1 5.091 1.013 8.315 8.315 0 0 0 5.713.636l.285-.071-3.954-3.955a3 3 0 0 1-.879-2.121v-5.02a23.614 23.614 0 0 0-3 0Zm4.5.138a.75.75 0 0 0 .093-1.495A24.837 24.837 0 0 0 12 2.25a25.048 25.048 0 0 0-3.093.191A.75.75 0 0 0 9 3.936v4.882a1.5 1.5 0 0 1-.44 1.06l-6.293 6.294c-1.62 1.621-.903 4.475 1.471 4.88 2.686.46 5.447.698 8.262.698 2.816 0 5.576-.239 8.262-.697 2.373-.406 3.092-3.26 1.47-4.881L15.44 9.879A1.5 1.5 0 0 1 15 8.818V3.936Z","clipRule":"evenodd"}]]}],["$","span",null,{"className":"text-sm leading-tight","children":"Syringe Services Programs (Needle Exchange)"}]]}]}]
15:["$","$L1d",null,{"sections":"$5:props:children:1:props:sections"}]
16:["$","div",null,{"className":"my-16","children":[["$","h2",null,{"className":"text-3xl font-bold text-gray-900 mb-2","children":"Path to Impact"}],["$","div",null,{"className":"h-1 w-20 bg-gradient-to-r from-sil-primary to-sil-teal-2 rounded-full mb-8"}],["$","div",null,{"className":"relative","children":[["$","div",null,{"className":"absolute left-4 md:left-1/2 top-0 bottom-0 w-0.5 bg-sil-teal-3/30 md:-ml-px"}],["$","div",null,{"className":"space-y-12","children":[["$","div","0",{"className":"relative flex flex-col md:flex-row gap-8 items-start","children":[["$","div",null,{"className":"absolute left-0 md:left-1/2 flex items-center justify-center md:-ml-4","children":["$","div",null,{"className":"w-8 h-8 bg-sil-teal-1 rounded-full border-4 border-white shadow-lg flex items-center justify-center","children":["$","div",null,{"className":"w-2 h-2 bg-white rounded-full"}]}]}],["$","div",null,{"className":"ml-12 md:ml-0 md:w-1/2 md:pr-12 md:text-right","children":["$","div",null,{"className":"bg-white border-2 border-sil-teal-3 rounded-lg p-6 hover:shadow-lg transition-shadow","children":[["$","p",null,{"className":"text-sil-teal-2 font-bold text-sm uppercase tracking-wider mb-2","children":"1985-1988"}],["$","h4",null,{"className":"text-xl font-bold text-black mb-2","children":"Underground Programs Begin"}],["$","p",null,{"className":"text-gray-600 text-sm leading-relaxed","children":"Community activists start first illegal needle exchanges in response to AIDS crisis hitting injection drug users"}]]}]}],["$","div",null,{"className":"hidden md:block md:w-1/2 "}]]}],["$","div","1",{"className":"relative flex flex-col md:flex-row gap-8 items-start","children":[["$","div",null,{"className":"absolute left-0 md:left-1/2 flex items-center justify-center md:-ml-4","children":["$","div",null,{"className":"w-8 h-8 bg-sil-teal-1 rounded-full border-4 border-white shadow-lg flex items-center justify-center","children":["$","div",null,{"className":"w-2 h-2 bg-white rounded-full"}]}]}],["$","div",null,{"className":"ml-12 md:ml-0 md:w-1/2 md:order-2 md:pl-12","children":["$","div",null,{"className":"bg-white border-2 border-sil-teal-3 rounded-lg p-6 hover:shadow-lg transition-shadow","children":[["$","p",null,{"className":"text-sil-teal-2 font-bold text-sm uppercase tracking-wider mb-2","children":"1989-1993"}],["$","h4",null,{"className":"text-xl font-bold text-black mb-2","children":"Early Research Evidence"}],["$","p",null,{"className":"text-gray-600 text-sm leading-relaxed","children":"Tacoma and New Haven studies demonstrate HIV risk reduction; first government programs authorized"}]]}]}],["$","div",null,{"className":"hidden md:block md:w-1/2 md:order-1"}]]}],["$","div","2",{"className":"relative flex flex-col md:flex-row gap-8 items-start","children":[["$","div",null,{"className":"absolute left-0 md:left-1/2 flex items-center justify-center md:-ml-4","children":["$","div",null,{"className":"w-8 h-8 bg-sil-teal-1 rounded-full border-4 border-white shadow-lg flex items-center justify-center","children":["$","div",null,{"className":"w-2 h-2 bg-white rounded-full"}]}]}],["$","div",null,{"className":"ml-12 md:ml-0 md:w-1/2 md:pr-12 md:text-right","children":["$","div",null,{"className":"bg-white border-2 border-sil-teal-3 rounded-lg p-6 hover:shadow-lg transition-shadow","children":[["$","p",null,{"className":"text-sil-teal-2 font-bold text-sm uppercase tracking-wider mb-2","children":"1995"}],["$","h4",null,{"className":"text-xl font-bold text-black mb-2","children":"CDC Report"}],["$","p",null,{"className":"text-gray-600 text-sm leading-relaxed","children":"Federal review finds SSPs reduce HIV transmission without increasing drug use"}]]}]}],["$","div",null,{"className":"hidden md:block md:w-1/2 "}]]}],["$","div","3",{"className":"relative flex flex-col md:flex-row gap-8 items-start","children":[["$","div",null,{"className":"absolute left-0 md:left-1/2 flex items-center justify-center md:-ml-4","children":["$","div",null,{"className":"w-8 h-8 bg-sil-teal-1 rounded-full border-4 border-white shadow-lg flex items-center justify-center","children":"$L1e"}]}],"$L1f","$L20"]}],"$L21","$L22"]}]]}]]}]
17:["$","section",null,{"className":"mt-16 pt-16 border-t border-gray-200","children":[["$","h2",null,{"className":"text-3xl font-bold text-black mb-4","children":"Lessons Exemplified"}],["$","p",null,{"className":"text-lg text-gray-600 mb-8","children":"This case study demonstrates these key lessons:"}],["$","div",null,{"className":"grid grid-cols-1 md:grid-cols-2 gap-6","children":[["$","$L8","1-public-engagement",{"href":"/lessons/1-public-engagement","className":"block bg-white border-2 border-sil-teal-3 rounded-lg p-6 transition-all hover:shadow-lg hover:-translate-y-1 hover:border-sil-teal-1","children":["$","article",null,{"className":"flex items-start gap-4","children":[["$","div",null,{"className":"flex-shrink-0 w-10 h-10 bg-sil-teal-1 text-white rounded-full font-bold text-lg flex items-center justify-center","children":1}],["$","div",null,{"children":[["$","h3",null,{"className":"text-lg font-bold text-black mb-1","children":"Public Engagement Matters"}],["$","p",null,{"className":"text-sm text-gray-600","children":"Learn more about this lesson →"}]]}]]}]}],["$","$L8","2-archetypes",{"href":"/lessons/2-archetypes","className":"block bg-white border-2 border-sil-teal-3 rounded-lg p-6 transition-all hover:shadow-lg hover:-translate-y-1 hover:border-sil-teal-1","children":["$","article",null,{"className":"flex items-start gap-4","children":[["$","div",null,{"className":"flex-shrink-0 w-10 h-10 bg-sil-teal-1 text-white rounded-full font-bold text-lg flex items-center justify-center","children":2}],["$","div",null,{"children":[["$","h3",null,{"className":"text-lg font-bold text-black mb-1","children":"Two Pathways to Impact"}],["$","p",null,{"className":"text-sm text-gray-600","children":"Learn more about this lesson →"}]]}]]}]}],["$","$L8","4-knowledge-brokers",{"href":"/lessons/4-knowledge-brokers","className":"block bg-white border-2 border-sil-teal-3 rounded-lg p-6 transition-all hover:shadow-lg hover:-translate-y-1 hover:border-sil-teal-1","children":["$","article",null,{"className":"flex items-start gap-4","children":[["$","div",null,{"className":"flex-shrink-0 w-10 h-10 bg-sil-teal-1 text-white rounded-full font-bold text-lg flex items-center justify-center","children":4}],["$","div",null,{"children":[["$","h3",null,{"className":"text-lg font-bold text-black mb-1","children":"Knowledge Brokers Matter"}],["$","p",null,{"className":"text-sm text-gray-600","children":"Learn more about this lesson →"}]]}]]}]}],["$","$L8","5-legitimacy-narrative",{"href":"/lessons/5-legitimacy-narrative","className":"block bg-white border-2 border-sil-teal-3 rounded-lg p-6 transition-all hover:shadow-lg hover:-translate-y-1 hover:border-sil-teal-1","children":["$","article",null,{"className":"flex items-start gap-4","children":[["$","div",null,{"className":"flex-shrink-0 w-10 h-10 bg-sil-teal-1 text-white rounded-full font-bold text-lg flex items-center justify-center","children":5}],["$","div",null,{"children":[["$","h3",null,{"className":"text-lg font-bold text-black mb-1","children":"How You Frame It Matters"}],["$","p",null,{"className":"text-sm text-gray-600","children":"Learn more about this lesson →"}]]}]]}]}],["$","$L8","6-policy-windows",{"href":"/lessons/6-policy-windows","className":"block bg-white border-2 border-sil-teal-3 rounded-lg p-6 transition-all hover:shadow-lg hover:-translate-y-1 hover:border-sil-teal-1","children":["$","article",null,{"className":"flex items-start gap-4","children":[["$","div",null,{"className":"flex-shrink-0 w-10 h-10 bg-sil-teal-1 text-white rounded-full font-bold text-lg flex items-center justify-center","children":6}],["$","div",null,{"children":[["$","h3",null,{"className":"text-lg font-bold text-black mb-1","children":"Timing and Readiness"}],["$","p",null,{"className":"text-sm text-gray-600","children":"Learn more about this lesson →"}]]}]]}]}],["$","$L8","7-long-timeline",{"href":"/lessons/7-long-timeline","className":"block bg-white border-2 border-sil-teal-3 rounded-lg p-6 transition-all hover:shadow-lg hover:-translate-y-1 hover:border-sil-teal-1","children":"$L23"}],"$L24"]}]]}]
18:["$","nav",null,{"className":"mt-16 pt-8 border-t border-gray-200","aria-label":"Case study navigation","children":["$","div",null,{"className":"grid grid-cols-1 md:grid-cols-2 gap-4","children":[["$","div",null,{"children":["$","$L8",null,{"href":"/case-studies/moving-to-opportunity","className":"group block p-6 border border-gray-200 rounded-lg hover:border-sil-primary hover:shadow-md transition-all duration-200","children":[["$","div",null,{"className":"flex items-center gap-2 text-sm font-semibold text-gray-500 mb-2","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","fill":"none","viewBox":"0 0 24 24","strokeWidth":1.5,"stroke":"currentColor","aria-hidden":"true","data-slot":"icon","className":"w-4 h-4","children":[null,["$","path",null,{"strokeLinecap":"round","strokeLinejoin":"round","d":"M15.75 19.5 8.25 12l7.5-7.5"}]]}],["$","span",null,{"children":"Previous"}]]}],["$","div",null,{"className":"text-lg font-semibold text-gray-900 group-hover:text-sil-primary transition-colors","children":"Moving to Opportunity"}]]}]}],["$","div",null,{"children":["$","div",null,{"className":"hidden md:block"}]}]]}]}]
1b:null
1e:["$","div",null,{"className":"w-2 h-2 bg-white rounded-full"}]
1f:["$","div",null,{"className":"ml-12 md:ml-0 md:w-1/2 md:order-2 md:pl-12","children":["$","div",null,{"className":"bg-white border-2 border-sil-teal-3 rounded-lg p-6 hover:shadow-lg transition-shadow","children":[["$","p",null,{"className":"text-sil-teal-2 font-bold text-sm uppercase tracking-wider mb-2","children":"1998-2011"}],["$","h4",null,{"className":"text-xl font-bold text-black mb-2","children":"Funding Battles"}],["$","p",null,{"className":"text-gray-600 text-sm leading-relaxed","children":"Despite evidence, federal funding ban remains in place due to political opposition"}]]}]}]
20:["$","div",null,{"className":"hidden md:block md:w-1/2 md:order-1"}]
21:["$","div","4",{"className":"relative flex flex-col md:flex-row gap-8 items-start","children":[["$","div",null,{"className":"absolute left-0 md:left-1/2 flex items-center justify-center md:-ml-4","children":["$","div",null,{"className":"w-8 h-8 bg-sil-teal-1 rounded-full border-4 border-white shadow-lg flex items-center justify-center","children":["$","div",null,{"className":"w-2 h-2 bg-white rounded-full"}]}]}],["$","div",null,{"className":"ml-12 md:ml-0 md:w-1/2 md:pr-12 md:text-right","children":["$","div",null,{"className":"bg-white border-2 border-sil-teal-3 rounded-lg p-6 hover:shadow-lg transition-shadow","children":[["$","p",null,{"className":"text-sil-teal-2 font-bold text-sm uppercase tracking-wider mb-2","children":"2015"}],["$","h4",null,{"className":"text-xl font-bold text-black mb-2","children":"Federal Funding Allowed"}],["$","p",null,{"className":"text-gray-600 text-sm leading-relaxed","children":"HIV outbreak in Indiana prompts federal policy shift; funding restrictions partially lifted"}]]}]}],["$","div",null,{"className":"hidden md:block md:w-1/2 "}]]}]
22:["$","div","5",{"className":"relative flex flex-col md:flex-row gap-8 items-start","children":[["$","div",null,{"className":"absolute left-0 md:left-1/2 flex items-center justify-center md:-ml-4","children":["$","div",null,{"className":"w-8 h-8 bg-sil-teal-1 rounded-full border-4 border-white shadow-lg flex items-center justify-center","children":["$","div",null,{"className":"w-2 h-2 bg-white rounded-full"}]}]}],["$","div",null,{"className":"ml-12 md:ml-0 md:w-1/2 md:order-2 md:pl-12","children":["$","div",null,{"className":"bg-white border-2 border-sil-teal-3 rounded-lg p-6 hover:shadow-lg transition-shadow","children":[["$","p",null,{"className":"text-sil-teal-2 font-bold text-sm uppercase tracking-wider mb-2","children":"2024"}],["$","h4",null,{"className":"text-xl font-bold text-black mb-2","children":"500 Programs Nationwide"}],["$","p",null,{"className":"text-gray-600 text-sm leading-relaxed","children":"40-60% HIV reduction proven; ~500 SSPs operate with 76% hepatitis C reduction in high-coverage areas"}]]}]}],["$","div",null,{"className":"hidden md:block md:w-1/2 md:order-1"}]]}]
23:["$","article",null,{"className":"flex items-start gap-4","children":[["$","div",null,{"className":"flex-shrink-0 w-10 h-10 bg-sil-teal-1 text-white rounded-full font-bold text-lg flex items-center justify-center","children":7}],["$","div",null,{"children":[["$","h3",null,{"className":"text-lg font-bold text-black mb-1","children":"Patient Capital Required"}],["$","p",null,{"className":"text-sm text-gray-600","children":"Learn more about this lesson →"}]]}]]}]
24:["$","$L8","8-different-roles",{"href":"/lessons/8-different-roles","className":"block bg-white border-2 border-sil-teal-3 rounded-lg p-6 transition-all hover:shadow-lg hover:-translate-y-1 hover:border-sil-teal-1","children":["$","article",null,{"className":"flex items-start gap-4","children":[["$","div",null,{"className":"flex-shrink-0 w-10 h-10 bg-sil-teal-1 text-white rounded-full font-bold text-lg flex items-center justify-center","children":8}],["$","div",null,{"children":[["$","h3",null,{"className":"text-lg font-bold text-black mb-1","children":"Research Roles Evolve"}],["$","p",null,{"className":"text-sm text-gray-600","children":"Learn more about this lesson →"}]]}]]}]}]
